Literature DB >> 18424336

Genetic defects of apoptosis and primary immunodeficiency.

Helen C Su1, Michael J Lenardo.   

Abstract

Programmed cell death is important for maintaining lymphocyte homeostasis. Several human-inherited diseases with impaired apoptosis have been identified at the genetic level: autoimmune lymphoproliferative syndrome, caspase-8 deficiency state, and X-linked lymphoproliferative syndrome. These diseases feature excess lymphocyte accumulation, autoimmunity, or immunodeficiency. Elucidating their molecular pathogenesis has also provided new insights into the signaling mechanisms regulating apoptosis and lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424336      PMCID: PMC2671802          DOI: 10.1016/j.iac.2008.01.002

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  89 in total

Review 1.  Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci.

Authors:  M Nose; M Nishihara; J Kamogawa; M Terada; S Nakatsuru
Journal:  Rev Immunogenet       Date:  2000

2.  Dominant expression of interleukin 10 but not interferon gamma in CD4(-)CD8(-)alphabetaT cells of autoimmune lymphoproliferative syndrome.

Authors:  Shouichi Ohga; Akihiko Nomura; Yasushi Takahata; Kenji Ihara; Hidetoshi Takada; Hiroshi Wakiguchi; Yuji Kudo; Toshiro Hara
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

3.  The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

Authors:  S E Straus; E S Jaffe; J M Puck; J K Dale; K B Elkon; A Rösen-Wolff; A M Peters; M C Sneller; C W Hallahan; J Wang; R E Fischer; C E Jackson; A Y Lin; C Bäumler; E Siegert; A Marx; A K Vaishnaw; T Grodzicky; T A Fleisher; M J Lenardo
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

4.  TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.

Authors:  J J Bleesing; M R Brown; J K Dale; S E Straus; M J Lenardo; J M Puck; T P Atkinson; T A Fleisher
Journal:  Clin Immunol       Date:  2001-09       Impact factor: 3.969

5.  Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.

Authors:  J J Bleesing; M R Brown; S E Straus; J K Dale; R M Siegel; M Johnson; M J Lenardo; J M Puck; T A Fleisher
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

6.  Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.

Authors:  U Lopatin; X Yao; R K Williams; J J Bleesing; J K Dale; D Wong; J Teruya-Feldstein; S Fritz; M R Morrow; I Fuss; M C Sneller; M Raffeld; T A Fleisher; J M Puck; W Strober; E S Jaffe; S E Straus
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.

Authors:  Jack J H Bleesing; Margaret R Brown; Cynthia Novicio; David Guarraia; Janet K Dale; Stephen E Straus; Thomas A Fleisher
Journal:  Clin Immunol       Date:  2002-07       Impact factor: 3.969

8.  Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome.

Authors:  Frederick D Goldman; Rajeev Vibhakar; Jennifer M Puck; Stephen E Straus; Zuhair K Ballas; Clay Hollenback; Thomas Loew; Anthony Thompson; Kejing Song; Robert T Cook
Journal:  Clin Immunol       Date:  2002-07       Impact factor: 3.969

9.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.

Authors:  Hyung J Chun; Lixin Zheng; Manzoor Ahmad; Jin Wang; Christina K Speirs; Richard M Siegel; Janet K Dale; Jennifer Puck; Joie Davis; Craig G Hall; Suzanne Skoda-Smith; T Prescott Atkinson; Stephen E Straus; Michael J Lenardo
Journal:  Nature       Date:  2002-09-26       Impact factor: 49.962

10.  Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome.

Authors:  Bridget T Heelan; Vincent Tormey; Peter Amlot; Elspeth Payne; Atul Mehta; A David B Webster
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

View more
  15 in total

Review 1.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 2.  Staying alive: cell death in antiviral immunity.

Authors:  Jason W Upton; Francis Ka-Ming Chan
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

3.  Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes.

Authors:  D V Delfino; S Spinicelli; N Pozzesi; S Pierangeli; E Velardi; S Bruscoli; M P Martelli; V Pettirossi; L Falchi; T-b Kang; C Riccardi
Journal:  Cell Death Differ       Date:  2010-07-30       Impact factor: 15.828

4.  Whole-exome-sequencing-based discovery of human FADD deficiency.

Authors:  Alexandre Bolze; Minji Byun; David McDonald; Neil V Morgan; Avinash Abhyankar; Lakshmanane Premkumar; Anne Puel; Chris M Bacon; Frédéric Rieux-Laucat; Ki Pang; Alison Britland; Laurent Abel; Andrew Cant; Eamonn R Maher; Stefan J Riedl; Sophie Hambleton; Jean-Laurent Casanova
Journal:  Am J Hum Genet       Date:  2010-11-25       Impact factor: 11.025

5.  A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect.

Authors:  María Gabriela Simesen de Bielke; Judith Yancoski; Carlos Rocco; Laura E Pérez; Claudio Cantisano; Néstor Pérez; Matías Oleastro; Silvia Danielian
Journal:  J Clin Immunol       Date:  2012-07-03       Impact factor: 8.317

Review 6.  Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response.

Authors:  Kelsey Voss; Sasha E Larsen; Andrew L Snow
Journal:  Cancer Lett       Date:  2017-09-01       Impact factor: 8.679

7.  The technological transformation of patient-driven human immunology research.

Authors:  Helen C Su
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 8.  Fueling the flames: Mammalian programmed necrosis in inflammatory diseases.

Authors:  Francis Ka-Ming Chan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

9.  Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.

Authors:  Jahnavi Aluri; Alicia Bach; Saara Kaviany; Luana Chiquetto Paracatu; Maleewan Kitcharoensakkul; Magdalena A Walkiewicz; Christopher D Putnam; Marwan Shinawi; Nermina Saucier; Elise M Rizzi; Michael T Harmon; Molly P Keppel; Michelle Ritter; Morgan Similuk; Elaine Kulm; Michael Joyce; Adriana A de Jesus; Raphaela Goldbach-Mansky; Yi-Shan Lee; Marina Cella; Peggy L Kendall; Mary C Dinauer; Jeffrey J Bednarski; Christina Bemrich-Stolz; Scott W Canna; Shirley M Abraham; Matthew M Demczko; Jonathan Powell; Stacie M Jones; Amy M Scurlock; Suk See De Ravin; Jack J Bleesing; James A Connelly; V Koneti Rao; Laura G Schuettpelz; Megan A Cooper
Journal:  Blood       Date:  2021-05-06       Impact factor: 25.476

Review 10.  Multiple roles of caspase-8 in cell death, inflammation, and innate immunity.

Authors:  Pontus Orning; Egil Lien
Journal:  J Leukoc Biol       Date:  2020-06-12       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.